Hypoxia-selective targeting of eEF1A1: A promising therapeutic strategy for triple-negative breast cancer
Acta Pharmaceutica Sinica B · 2026-05 · 16 (5) · 3249-3250
DOI: 10.1016/j.apsb.2026.04.013 ↗Kurz gefasst
Editorial in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-05. Verfasst von Steven H Liang. Beteiligte Einrichtung: Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30322, USA. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA 30322, USA.
Zitieren
APA
Liang, S. H. (2026). Hypoxia-selective targeting of eEF1A1: A promising therapeutic strategy for triple-negative breast cancer. Acta Pharmaceutica Sinica B, 16(5), 3249-3250. https://doi.org/10.1016/j.apsb.2026.04.013
Vancouver
Liang SH. Hypoxia-selective targeting of eEF1A1: A promising therapeutic strategy for triple-negative breast cancer. Acta Pharmaceutica Sinica B. 2026;16(5):3249-3250. doi:10.1016/j.apsb.2026.04.013
BibTeX
@article{Liang2026,
author = {Liang, Steven H},
title = {Hypoxia-selective targeting of eEF1A1: A promising therapeutic strategy for triple-negative breast cancer},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {5},
pages = {3249--3250},
doi = {10.1016/j.apsb.2026.04.013}
}
EUVIMED